Khalil Barrage - 26 May 2021 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
Director
Signature
/s/ Alexander Arrow, as attorney-in-fact
Issuer symbol
PTIX
Transactions as of
26 May 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 18:54:37 UTC
Next filing
29 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTIX PTIX Common stock NSO Options Award $0 +180,000 $0.000000 180,000 26 May 2021 PTIX common stock, Par Value $0.000001 180,000 $3.65 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise price was determined by the Board of Directors at a Board Meeting held May 26, 2021.
F2 This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021.
F3 The options are fully vested.

Remarks:

Ex. 24, Power of Attorney